PinnacleHealth CardioVascular Institute last week enrolled the first patient in the United States in a trial assessing the safety and effectiveness of a new type of approach for blockages in the leg artery.

Corindus Vascular Robotics Inc. announced that the first robotic-assisted percutaneous coronary intervention (PCI) procedures were performed in Asia using its CorPath GRX System. One of these procedures was transmitted live from Fu Wai Hospital to the more than 8,000 attendees at the China Interventional Therapeutics Conference. The annual conference, being held in Beijing, China this year, is the largest interventional cardiology conference in the Asia Pacific region.

Biotronik announced the European launch of a new lead for tachycardia therapy that features a helical design for increased long-term performance through stress reduction. The Plexa ProMRI lead is made for use with implantable cardiac defibrillators (ICDs) as well as cardiac resynchronization therapy defibrillators (CRT-Ds).

April 11, 2017 — IBA Molecular announced that it has merged with previous acquisition Mallinckrodt Nuclear Medicine LLC to form the new company Curium.

April 10, 2017 — Boston Scientific recently announced a $435 million cash deal to acquire Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices.